NCT07094048
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Santé Québec Chaudière-Appalaches Lévis, Quebec, Canada
- Centre Intégré de Cancérologie Québec, Quebec, Canada
Clinical trial condition
Relapsed Multiple Myeloma
Explore clinical trials studying Relapsed Multiple Myeloma. Study availability and eligibility vary by location and protocol.
27 public trials
5 recruiting studies
Relapsed Multiple Myeloma trial results
NCT06433947
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Banner MD Anderson Gilbert, Arizona, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Stanford Cancer Institute Stanford, California, United States
- Emory Winchip Cancer Center Atlanta, Georgia, United States
NCT06348108
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University of Calfornia, San Francisco San Francisco, California, United States
NCT05896228
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University of Miami Miami, Florida, United States
NCT06119685
- Conditions
- Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +23 more
- Locations
-
- Valkyrie Clinical Trials Los Angeles, California, United States
- Florida Cancer Specialists and Research Institute - Lake Mary Cancer Center Lake Mary, Florida, United States
- Emory University Hospital Atlanta, Georgia, United States
- University of Minnesota Minneapolis, Minnesota, United States
Not yet recruiting
INfections in Patients Treated With CAR-T
NCT07713511
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bloodstream Infections, +29 more
- Locations
-
- IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
Active, not recruiting
A Trial for Relapsed Multiple Myeloma Patients (Isatuximab-dexamethasone)
NCT04965155
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- AOU Policlinico di Bari Bari, Italy
- I.R.C.C.S. Ospedale S. Raffaele Milan, Italy
- AO di Perugia-Ospedale S. Maria della Misericordia Perugia, Italy
- Policlinico Umberto I - Università 'Sapienza' Roma, Italy
Active, not recruiting
A Clinical Study to Evaluate the Effects of RO7875913 in Healthy Participants and of RO7875913 With Cevostamab in Participnats With With Relapsed/Refractory Multiple Myeloma
NCT07342114
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Healthy Volunteers, +15 more
- Locations
-
- New Zealand Clinical Research - Christchurch Christchurch, Canterbury, New Zealand
Active, not recruiting
Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide
NCT05060627
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Hospital Germans Trias i Pujol (ICO BADALONA) Badalona, Spain
- Hospital Clinic Barcelona, Spain
- ICO Duran i Reynals L'Hospitalet de Llobregat, Spain
- H. Gregorio Marañón Madrid, Spain
Active, not recruiting
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
NCT05577000
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States